Pharmacology & ToxicologyAntimicrobial Agents and ChemotherapyPeer-reviewed
Sulbactam-Durlobactam Plus Ceftriaxone Dosing and Novel Treatment Regimens for Mycobacterium abscessus Lung Disease
Sanjay Kumar Singh, Avneesh Shrivastava, Gunavanthi D. Boorgula…·Shashikant Srivastava
This study evaluates sulbactam-durlobactam plus ceftriaxone dosing and combination regimens for Mycobacterium abscessus lung disease, finding that sulbactam-durlobactam-ceftriaxone achieves the highest microbial kill in a hollow fiber model.
3 citations